Hexagon Nutrition's ₹138 Crore IPO Opens June 5 — India's Only Confirmed Mainboard Listing of the Month

In a primary market that has stayed unusually quiet through the first half of 2026, a 33-year-old Mumbai nutrition pioneer steps forward as the lone mainboard debutant of June — carrying with it a global footprint, a profitable balance sheet, and a story of quiet, compounding strength.

By The Impactful Global Indian · IPO & Markets Desk

When the Indian primary market goes quiet, it tends to go very quiet.

The first five months of 2026 told that story clearly. Mainboard IPOs all but vanished from Dalal Street, leaving SME offerings to carry the entire load of investor interest. In that context, Hexagon Nutrition Ltd stepping forward as the sole confirmed mainboard IPO of June 2026 carries significance well beyond its modest ₹138.87 crore issue size.

This is not just another listing.

It is the opening of what analysts hope will be a long-awaited revival of India's mainline primary market.

For the discerning investor — particularly the Global Indian professional who understands that nutrition, health, and food security are defining investment themes of this decade — Hexagon Nutrition is a name worth examining carefully. It is not a speculative startup chasing a valuation. It is a 33-year-old, research-driven company with a genuine international footprint, real profitability, and a product range that sits squarely in the centre of one of the world's fastest-growing sectors.

About the Company

Incorporated in 1993 in Mumbai, Hexagon Nutrition Ltd has built its business across four core verticals: micronutrient premix formulations (B2B), branded wellness and clinical nutrition (B2C), therapeutic formulations, and ready-to-use foods.

Its brands — Pentasure, Obesigo, Pediagold, and Nutrone — are established names in the clinical nutrition and wellness pharmacy space across India.

The company operates three manufacturing facilities in India — in Maharashtra and Tamil Nadu — plus an additional unit in Uzbekistan, strategically positioned to serve Central Asian and Middle Eastern markets.

Products carry international quality certifications including FSSC 22000, GMP, ISO 9001:2015, and Halal. Over 358 distributors serve its domestic network, including eight multi-state partners. As of March 2026, the company employed 527 people across its operations.

"Products from Hexagon Nutrition have reached over 75 countries across Asia, Africa, Europe, and South America — a global footprint that most Indian mainboard companies three times its size would envy."

— IPO Central Research, May 2026

The Financial Picture

Numbers do not lie — and Hexagon Nutrition's tell a story of disciplined, profitable growth.

The company has moved from ₹278.5 crore in revenue in FY23 to ₹331.29 crore in FY25, with export sales consistently accounting for over 61 percent of total revenue.

More strikingly, its Profit After Tax doubled between FY24 and FY25 — rising from ₹12.21 crore to ₹24.38 crore — a 100 percent improvement in bottom-line profitability in a single year.

What makes the 9M FY26 data particularly compelling is that Hexagon's PAT of ₹27.03 crore for just the first nine months of FY26 already exceeds its full-year FY25 PAT of ₹24.38 crore.

This trajectory suggests the company is entering its IPO on a genuine earnings acceleration cycle.Its debt-to-equity ratio of 0.18 indicates a conservatively leveraged balance sheet — a significant comfort factor in today's elevated interest rate environment.

IPO Structure — The OFS Question

Investor Alert: Offer For Sale Structure

The Hexagon Nutrition IPO is structured entirely as an Offer For Sale (OFS) of up to 3.09 crore equity shares.

This means no fresh capital is raised for the company. All proceeds flow directly to the selling shareholders, primarily the promoter family. The company receives no funds from this public issue.While this does not diminish the company's business merit, investors should note that an OFS does not fund expansion, debt reduction, or new projects.

The IPO reservation structure allocates 50 percent of the issue to Qualified Institutional Buyers (QIBs), 15 percent to Non-Institutional Investors (NIIs), and 35 percent to retail investors — a retail-friendly allocation for a mainboard issue.The anchor investor date is June 4, ahead of the public subscription window.Lead managers are Cumulative Capital Pvt. Ltd. and Catalyst Capital Partners. Registrar: Kfin Technologies Ltd.

The Sector Tailwind: Why Nutrition Matters Now

India is in the middle of a nutrition revolution.

The post-pandemic consumer has fundamentally reprioritised health expenditure. The clinical nutrition market — Hexagon's stronghold — is growing rapidly as an ageing population, increasing lifestyle disease burden, and expanding health insurance penetration drive demand for specialised therapeutic and preventive nutrition products.

The ready-to-use foods segment benefits from both domestic government nutrition programmes and global humanitarian supply chains.

Why The Global Indian Should Pay Attention

For NRI investors with SEBI-registered Demat accounts, Hexagon Nutrition represents a relatively low-risk entry into India's growing healthcare-adjacent nutrition sector.

At ₹14,985 minimum investment for one lot, the ticket size remains accessible.

With more than 61 percent of revenues coming from exports, the company carries natural currency diversification. And with the mainboard IPO market expected to accelerate in the second half of 2026 with potential listings from NSE, Reliance Jio, and others, Hexagon offers a measured, fundamentals-driven entry point ahead of that wave.

The Larger Picture: A Dry Market Finally Stirs

The Indian mainboard IPO market has been in extended hibernation through the first five months of 2026 — a sharp contrast to 2025's record fundraising activity.

Hexagon Nutrition's launch, modest as it is in absolute size, is therefore a bellwether moment.

If it lists well, it could signal to the dozen-plus major companies waiting in the pipeline — NSE, Reliance Jio, Acko, OYO, PhonePe, Zepto, and more — that market appetite has returned and the listing window is open.

For investors, Hexagon Nutrition offers something that has been in short supply in the primary market this year: a straightforward, listed-sector business with verifiable financials, a three-decade track record, and an entry price that — at ₹42 to ₹45 per share — does not require one to bet on a distant, speculative future.The story is already being written.The question is whether the listing price on June 12 will reward those who recognised it first.